Dong-A Pharmaceutical Co.,Ltd. New executive Kwon Soon-hwan reports holding 26 shares
AI summary · Not investment advice
Newly appointed executive Kwon Soon-hwan reported holding 26 common shares, a 0.00% stake.
Key facts
- Relationship with issuer
- Unregistered executive, Managing Director (Sangmu)
- Date of change
- Nov 1, 2026
Commentary
AI commentary · Not investment advice
What happened
Dong-A Pharmaceutical's executive Kwon Soon-hwan filed a first-time report saying he holds 26 shares of the company.
In the company's terms
This is a new report, which is filed when a person newly becomes an executive. He is an unregistered executive (an officer not on the board of directors) with the title of managing director. The shares he holds are common shares.
What changes for shareholders
The filing lists his ownership ratio as 0.00% of the company's issued shares. The materials give no later schedule or plans for further trades.
Earlier Insider Ownership filings from this company
| Filed | Title | Key figure · Note |
|---|---|---|
| 26.11.062026.11.06 | Insider Ownership | 67 shares · Common shares held following new appointment |
| 26.11.062026.11.06 | Insider Ownership | 30 shares |
| 26.11.062026.11.06 | Insider Ownership | 220 shares · Common shares held after change due to new appointment |
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
D